PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 187 filers reported holding PORTOLA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 5.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,180,000 | -70.7% | 49,431 | -67.1% | 2.12% | -75.5% |
| Q3 2019 | $4,031,000 | -71.7% | 150,299 | -71.4% | 8.64% | +11.9% |
| Q2 2019 | $14,263,000 | +123.5% | 525,730 | +185.9% | 7.72% | -27.6% |
| Q1 2019 | $6,381,000 | +92.1% | 183,902 | +8.1% | 10.66% | +16.2% |
| Q4 2018 | $3,321,000 | -50.5% | 170,129 | -32.5% | 9.18% | +48.1% |
| Q3 2018 | $6,708,000 | +103.9% | 251,881 | +189.1% | 6.20% | +91.6% |
| Q2 2018 | $3,290,000 | – | 87,116 | – | 3.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 228,873 | $7,475,000 | 4.17% |
| PFM Health Sciences, LP | 5,326,671 | $173,969,000 | 3.54% |
| Marcus Capital, LLC | 22,950 | $750,000 | 2.76% |
| Partner Investment Management, L.P. | 72,284 | $2,361,000 | 2.55% |
| CADIAN CAPITAL MANAGEMENT, LP | 1,240,944 | $40,529,000 | 2.19% |
| HARVEY CAPITAL MANAGEMENT INC | 158,580 | $5,179,000 | 1.94% |
| SECTORAL ASSET MANAGEMENT INC | 498,412 | $16,278,000 | 1.78% |
| Everett Capital Advisors UK LLP | 551,173 | $18,001,000 | 1.52% |
| ROSENBLUM SILVERMAN SUTTON S F INC /CA | 125,210 | $4,089,000 | 1.46% |
| Atika Capital Management LLC | 113,000 | $3,691,000 | 1.26% |